Molecular Formula | C22H20N2O3 |
Molar Mass | 360.41 |
Density | 1.253±0.06 g/cm3(Predicted) |
Boling Point | 429.9±40.0 °C(Predicted) |
Solubility | 10 mM in DMSO |
pKa | 13.21±0.70(Predicted) |
Storage Condition | 2-8°C |
In vitro study | ML365 blocks TASK1 channels in both the thallium influx fluorescent assay (IC 50 = 4 nM) and an automated electrophysiology assay (IC 50 = 16 nM). ML365 displays little or no inhibition at 30 μM of more distantly related potassium channels, Kir2.1, potassium voltage-gated channel, KQT-like subfamily, member 2 (KCNQ2), and human ether-a go-go-related gene (hERG). ML365 does not exhibit acute toxicity in cell-based assays at concentrations up to 30 μM. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.775 ml | 13.873 ml | 27.747 ml |
5 mM | 0.555 ml | 2.775 ml | 5.549 ml |
10 mM | 0.277 ml | 1.387 ml | 2.775 ml |
5 mM | 0.055 ml | 0.277 ml | 0.555 ml |
biological activity | ML365 is a novel small molecule inhibitor of TASK1 or KCNK3. |
Target | TargetValue TASK1/KCNK3 () |
Target | Value |
in vitro study | ML365 blocks TASK1 channels in and an automated electrophysiology assay (IC 50=16 nM). ML365 displays little or no inhibition at 30 μm of more different related pot channels, Kir2.1, pot voltage-gated channel, KQT-like subffamily, member 2 (KCNQ2), and human ether-a go-go-related gene (hERG). ML365 does not exhibit acute toxicity in cell-based assays at concentrations up to 30 μM. |